Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021

SELL
$93.66 - $139.27 $289,503 - $430,483
-3,091 Closed
0 $0
Q1 2021

May 20, 2021

BUY
$116.57 - $155.01 $3,263 - $4,340
28 Added 0.91%
3,091 $407,000
Q4 2020

Mar 09, 2021

BUY
$99.61 - $142.12 $298 - $426
3 Added 0.1%
3,063 $405,000
Q2 2020

Aug 19, 2020

BUY
$55.75 - $92.75 $170,595 - $283,815
3,060 New
3,060 $266,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Tru Independence LLC Portfolio

Follow Tru Independence LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru Independence LLC with notifications on news.